ReviewTherapeutic advances in endocrinology and metabolism2015

Update on long-term efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus.

Aris Liakos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.